DermWire TV

Episodes 33-48 of 141

FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
DermWire TV
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
DermWire TV Extra: How ILDS Helps Dermatology Go Global
DermWire TV Extra: How ILDS Helps Dermatology Go Global
DermWire TV
DermWire TV Extra: How ILDS Helps Dermatology Go Global
- Neal Bhatia, MD
- Henry Lim, MD
Dermatology and CTCL: Recommendations
Dermatology and CTCL: Recommendations
DermWire TV
Dermatology and CTCL: Recommendations
- Larisa J. Geskin, MD
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
DermWire TV
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
DermWire TV
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
DermWire TV
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
Skin Cancer & Photoprotection
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
- Neal Bhatia, MD, FAAD
- Todd E. Schlesinger, MD
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
Atopic Dermatitis
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
- Alexandra Golant, MD, FAAD
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermWire TV
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermWire TV
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
DermWire TV
DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermWire TV
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermWire TV
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
DermWire TV
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWire TV
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWire TV
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD

3/8